Mastering Immunity Europe 2021


Understand and manage immune responses in any setting



Thursday 25 March, 2021

9:00am GMT / 10:00am CET


Register Today

Early bird discount ends Wednesday 24 February, 2021

As targeted immune therapies grow in complexity, understanding and characterizing immune responses has never been more important. Join us at Mastering Immunity Europe 2021 to learn the latest developments in this evolving field. This meeting is a forum to share knowledge, perspectives and discuss solutions to the complex challenges of immunity following the delivery of biologics and other therapies.

Learn from academic and commercial experts as they highlight their discoveries in the context of both desired (in immuno-oncology and vaccines) and unwanted immune responses (i.e. immunogenicity to biotherapeutics or viral vectors). Share information with like-minded scientists from other organizations and explore new opportunities for collaboration. Discover fresh perspectives and novel ideas to combat the challenges in the rapidly changing field of immunology.


2021 Confirmed Speakers

NameTalk Title
Prof. Linda Wooldridge,
University of Bristol
The use of T-cell antigen discovery approaches to elucidate mechanisms of disease.
Dr. Cynthia Kramer,
Leiden University
Generation and reactivity analysis of human recombinant monoclonal antibodies directed against epitopes on HLA-DR
Dr. Amy Flaxman,
University of Oxford
Antibody responses to viral-vectored coronavirus vaccines
Dr. Derek Doherty,
Trinity College Dublin
CD1d-restricted T cells in patients with oesophageal cancer
Dr. Zuben Sauna,
FDA
TBC
Dr. Jeremy Fry,
ProImmune
An integrated approach to managing immunogenicity risk and drug immune modulation
Dr. Geoff Hale,
mABSOLVE
Characterisation of novel antibodies which are completely silenced with respect to Fc binding function
Prof. Daniel Olive
IBiSA Cancer Immunomonitoring Platform
Liquid Biopsy using K-Cytof demonstrates a role for Vg9Vd2 T cells as prognostic factor in breast cancer
Ms. Emma Doggett,
ProImmune
Clinical Immune Monitoring in Gene Therapy and Immuno-Oncology Programs
Dr. Tom Henley,
Empyrean Therapeutics
COVID-19 and Potential Future Pandemics: Virus Induced Lymphocytes (VIL)
Dr. Quirin Hammer,
Karolinska Institute
TBC


Mastering Immunity At a Glance

See highlights and feedback from speakers and attendees from Mastering Immunity Europe



Speakers from previous years

Presentations from our meetings are available online free of charge.

Dr. Lea Bartsch,
Massachusetts General Hospital
Dr. Inderpal Singh,
TEVA Pharmaceuticals
Dr. Zuben Sauna,
FDA
Prof. Tao Dong,
University of Oxford
Prof. Arlene Sharpe,
Harvard University
Dr. Laurent Malherbe, Eli LillyDr. David Wraith,
Apitope
Dr. Priya Sriraman, Celgene
Dr. Vibha Jawa,
Merck
Dr. Rodd Polsky,
GSK
Prof. Farzin Farzeneh,
Kings College London
Dr. Nina Le Bert
Duke NUS
Dr. Tim Hickling,
Roche
Prof. Beatriz Carreno,
University of Pennsylvania
Dr. Jochem Gokemeijer,
Bristol-Myers Squibb
Dr. Sophie Tourdot,
Pfizer


How will I benefit?

  • Be informed of the latest
    strategies for preclinical and clinical immune modulation
  • Quality by Design in drug
    development
  • Case Studies
  • Learn the key issues facing
    drug developers

Conference Enquiries:

Email: enquiries@proimmune.com

Telephone (toll free): USA & Canada +1 888 505 7765